---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-008364"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2023-03-21T23:59:59+00:00"
generated_at: "2026-06-17T21:57:43.162570+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pure Bioscience names Robert Bartlett CEO; Tom Lee resigns, stays on Board

## Summary
- Tom Y. Lee resigned as President and CEO effective March 15, 2023; will continue on Board.
- Robert Bartlett, Board member since Feb 2023, appointed President and CEO; base salary $300k, sign-on $17.5k.
- Bartlett granted option to purchase 500k shares, vesting quarterly over one year.
- Tom Myers transitioned from COO to EVP Technology and Development; remains on Board.
- Kristin A. Taylor resigned from Board effective March 19, 2023; no disagreement.

## SEC filing metadata
- accession: 0001493152-23-008364
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2023-03-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-008364
- JSON: https://secwatch.observer/filing/0001493152-23-008364.json
- Plain text: https://secwatch.observer/filing/0001493152-23-008364.txt

## Key facts
- Executive change
  Robert Bartlett was appointed as President and Chief Executive Officer at PURE BIOSCIENCE, INC..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: the Board appointed Robert Bartlett, a member of the Board, as the Company’s President and Chief Executive Officer, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm
- Executive change
  Tom Myers departed as Executive Vice President, Technology and Development at PURE BIOSCIENCE, INC..
  - Action: resigned as COO and transitioned to EVP
  - Role: Executive Vice President, Technology and Development
  source text: Tom Myers, the Company’s Chief Operating Officer and member of the Board, resigned as the Company’s Chief Operating Officer in connection with his transition to the Company’s Executive Vice President, Technology and Development, each effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm
- Executive change
  Kristin A. Taylor resigned as Director at PURE BIOSCIENCE, INC..
  - Action: resigned
  - Role: Director
  source text: On March 19, 2023, Kristin A. Taylor delivered notice to the Board of her resignation from the Board, effective March 19, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm
- Executive change
  Tom Y. Lee resigned as President and Chief Executive Officer at PURE BIOSCIENCE, INC..
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: Tom Y. Lee, the President, Chief Executive Officer and member of the Board of Directors (the “Board”) of Pure Bioscience, Inc. (the “Company”), resigned as the Company’s President and Chief Executive Officer, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.